Lipocine Inc. (LPCN) Cash per Single Share

Lipocine Inc. - graphic logo of issuer LPCN

The liquid assets per share metric on the GURU.Markets chart reveals the efficiency of the Lip'ral IT platform's test automation. The metric value stands at 1.92, confirming financial stability within a secure US legal framework. The high authority of Lipocine Inc. (LPCN) in endocrinology is based on the creation of convenient tablet forms of hormones, fostering patient trust.

LPCN - Lipocine Corp Cash per Share over the range 07/04/2022 - 11/20/2026

Analytical breakdowns for Lipocine Inc.

- market value and analyst target forecast:
- cash availability and cash flow indicators:
Summary company analysis:LPCN Lipocine Corp
Manufactured products of Lipocine Corp

Lipocine Inc. develops biopharmaceutical agents within a stable US legal framework, which minimizes external risks. This indicator reflects the amount of free cash flow per common share. Analyzing liquid assets per share allows for an assessment of the capital's real margin of safety against operating expenses. An increase in this metric confirms financial stability, while a decrease signals intensive cash burn. The asset belongs to the high-risk R&D sector.